Myomo (MYO) Income from Non-Controlling Interests (2019)
Myomo's (MYO) quarterly Income from Non-Controlling Interests came in at -$2.8 million in Q4 2019, up 0.95% quarter-over-quarter from -$2.8 million in Q3 2019.
Powered by 
Analysis
Myomo (MYO) Income from Non-Controlling Interests (2019) Analysis & Trends
Myomo (MYO) has reported Income from Non-Controlling Interests for 1 consecutive years, with -$2.8 million the latest figure, recorded in Q4 2019.
- For the quarter ending Q4 2019, Income from Non-Controlling Interests changed N/A year-over-year to -$2.8 million; the trailing twelve-month figure through Dec 2019 stood at -$11.5 million (changed N/A YoY), and the FY2019 full-year result was -$11.5 million, changed N/A from the prior year.
- Income from Non-Controlling Interests advanced to -$2.8 million in Q4 2019 per MYO's latest filing, from -$2.8 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at -$2.6 million in Q2 2019 and bottomed at -$3.4 million in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 900,000.00 |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -2.76 Mn |
| Sep 30, 2019 | -2.79 Mn |
| Jun 30, 2019 | -2.57 Mn |
| Mar 31, 2019 | -3.40 Mn |